EnzymeBioSystems
A Nevada Corporation
8250 W. Charleston Blvd., Suite 120
Las Vegas, NV 89117
Telephone: (702) 907-0615
March 19, 2018
EDGAR SUBMISSION
U. S. Securities and Exchange Commission
Department of Corporate Finance
Office of Healthcare & Insurance
100 F. Street, N.E.
Washington, D.C. 20549
| Re: | EnzymeBioSystems Request to Withdraw Request for Withdrawal of Registration Statement on Form S-1 File No. 333-222503 |
Ladies & Gentlemen:
On behalf of EnzymeBioSystems, a Nevada corporation (“Company”), on or about March 16, 2018, we made a request pursuant to Rule 477 of the Securities Act of 1933, as amended (“Securities Act”), that the Company’s Registration Statement on Form S-1, together with all exhibits and amendments thereto (File No. 333-222503), as initially filed with the U. S. Securities and Exchange Commission (“Commission”) on January 11, 2018 (“Registration Statement”) be withdrawn.
By this letter, we are withdrawing the Company’s request to withdraw the Registration Statement.
If you have any questions regarding this application for withdrawal, please contact the Registrant at (702) 907-0615.
| Very truly yours, | |
| /s/ John Dean Harper | |
| John Dean Harper | |
| Chief Executive Officer |
